Table 5.
CD4+ T-cell subsets in bleeding grade 1 patients, bleeding grade 2 or 3 patients, and HCs.
| Group Subset |
ITPgrade 1 BM (n = 20) |
ITPgrade 2+3 BM (n = 7)§ |
ITPgrade 1 PB (n = 20) |
ITPgrade 2+3 PB (n = 7)§§ |
HC BM (n = 20)&&1, &&2 |
HC PB (n = 7)&&&1, &&&2 |
|---|---|---|---|---|---|---|
| Th22 (%) | 2.03 ± 0.72 | 2.54 ± 0.65$ | 1.31 ± 0.53 | 1.78 ± 0.50* | 0.84 ± 0.17#,# | 0.83 ± 0.16#,# |
| Th17 (%) | 3.26 ± 1.16 | 3.36 ± 1.10$ | 2.10 ± 0.92 | 2.36 ± 0.66$ | 1.39 ± 0.17#,# | 1.32 ± 0.22#,# |
| Tregs (%) | 1.89 ± 0.82 | 1.49 ± 0.48$ | 4.00 ± 1.21 | 3.47 ± 1.20$ | 6.12 ± 0.30#,# | 6.21 ± 0.18#,# |
| Th17/Tregs | 2.15 ± 1.29 | 2.63 ± 1.81$ | 0.70 ± 0.69 | 0.84 ± 0.64$ | 0.19 ± 0.03#,# | 0.18 ± 0.03#,* |
| Th1 (%) | 24.19± 6.00 | 30.28 ± 6.72# | 17.37 ± 5.02 | 19.13 ± 7.94$ | 7.70 ± 1.12#,# | 7.11 ± 1.33#,# |
ITPgrade 1: Bleeding grade 1 patients; ITPgrade 2+3: Bleeding grade 2 or 3 patients. &&1ITPgrade 1 BM vs. HC BM, &&2ITPgrade 2+3 BM vs. HC BM, &&&1ITPgrade 1 PB vs. HC PB, &&&2ITPgrade 2+3 PB vs. HC PB, §ITPgrade 1 BM vs. ITPgrade 2+3 BM, §§ITPgrade 1 PB vs. ITPgrade 2+3 PB. *P < 0.05, #P < 0.01, $P > 0.05.